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Abstract. Placental-site trophoblastic tumor (PSTT) is a rare form of gestational
trophoblastic neoplasia. The clinical behaviour of PSTT is usually benign, but
sometimes it can be highly malignant with late recurrence and metastasis. We 
describe two cases of PSTT with pulmonary metastasis in patients aged 35 and 
29 years respectively. The mitotic rate was elevated to 9 and 13 mitotic figures per
10 high-power fields respectively. Immunohistochemical staining showed a pre-
dominance of human placental lactogen (hPL) positive cells when compared with
human chorionic gonadotropin (hCG) reactive cells in one case, and a reverse pat-
tern in the other one. DNA measurement in one case showed an aneuploid tumor
with a tetraploid DNA peak. The clinical behaviour of PSTT remains unpredict-
able, and there are no reliable means of predicting clinical outcome.
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Introduction
Placental site trophoblastic tumor (PSTT) is a rare form of gestational trophoblas-
tic disease; its epidemiology and risk factors are not well known. This neoplasm
is composed primarily of intermediate trophoblast and lacks the mixture of cyto-
and syncytiotrophoblast observed in choriocarcinoma. The histologic appearence
echoes the infiltration of the endometrium and myometrium of the placental site
[13]. The clinical behaviour of PSTT is usually benign, but can be highly malig-
nant [7]. And there are no reliable histologic, immunohistochemical, or DNA ploidy
predictors of clinical outcome [5, 11, 13]. We report two cases of PSTT with pul-
monary metastases and malignant outcome. We studied them with immunohisto-
chemical methods and DNA image analysis.
Arch Gynecol Obstet (1997) 259: 97–103
Correspondence to: S. Remadi
Case report
Case 1
A 35 year old woman, gravida 3, para 3, was admitted to the hospital with a history of irregular
vaginal bleeding for 6 months. The last delivery of a normal infant was 22 months previously.
Six years previously a complete hydatidiform mole had been diagnosed and treated with metho-
trexate. On admission physical examination revealed an enlarged uterus. Curetage yielded a large
amount of soft, haemorrhagic material. Histologic examination showed PSTT within the endo-
metrial fragments. A total hysterectomy with wedge resection of the right ovary and omental 
biopsy were done. The uterus weighed 200 gr and measured 4×8×11 cm. On gross examination
the endometrial mucosa was unremarkable. The lumen contained some bloody material. Within
the uterine wall there was a soft whitish area of about 2 cm with hemorrhagic foci. The cervix,
ovarian and omental tissue were unremarkable.
Histologically the curettings and the soft whitish area of the uterine wall showed tumor tis-
sue composed of large rounded or polyhedral intermediate trophoblastic cells, arranged in irreg-
ular nests. These cells had variably sized hyperchromatic nuclei, with irregular smudgy chrom-
atin. The cytoplasm was abundant, amphophilic, with well-defined boundaries (Fig. 1 A).
Most tumor cells were mononucleate, but multinucleate cells and giant nuclei were common.
Areas of extensive necrosis and fibrinoid material were observed. At the periphery the tumor in-
filtrated as single cells and small groups of cells dissecting between muscle fibers. Vascular in-
vasion was common. The mitotic index was 13 mitoses per 10 high-power fields (hpf). Endo-
metrial glands were inactive.
The histology of the pulmonary metastasis was similar to that observed in the curettings
(Fig. 1 B). Immunohistochemical analyses of the primary tumor showed a strong diffuse posi-
tivity for cytokeratin (wide spectrum), whereas a weak positivity was detected for CK 20 and
Epithelial Membrane Antigen (EMA). Reactivity to hPL was observed focally in occasional cells
(Fig. 2 B), whereas reactivity for hCG predominated (Fig. 2 A). A similar immunoreactivity was
observed in the pulmonary metastases. Cellular DNA measurement of the primary tumor by im-
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Fig. 1. Case 1: sheets of rounded-to-polygonal pleomorphic intermediate trophoblastic cells (A).
(Hematoxylin-eoxin ×300). Malignant intermediate trophoblastic cells invading the alveolar lu-
men (B). (Hematoxylin-eosin ×100)
age analysis showed an aneuploid tumor with a tetraploid DNA peak, and a prominent S-phase
fraction (Fig. 3).
Follow-up with hCG serum levels was unremarkable. Eleven months later the patient pre-
sented with a right spontaneous pneumothorax and accumulation of a small amount of pleural
fluid in the right pleural cavity.
Tomography revealed a small parenchymal infiltrate at the right lung base. Fine needle aspi-
ration of this infiltrate was not diagnostic. An open lung biopsy was performed and a hemor-
rhagic fragment of tissue of 1.0 cm in diameter was removed.
The patient received chemotherapy with EMA-Co regimen (VP-16, Actinomycin D, Metho-
trexate, Folinic acid, Vincristine, Cytoxan) and is at present clinically free of tumor.
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Fig. 2. Case 1: tumor cells reactive with anti-hCG antibody (A) predominate when compared
with tumor cells reactive with anti-hPL antibody (B). (Immunoperoxidase ×300)
Fig. 3. DNA histogram
showing an aneuploid pat-
tern with a tetraploid peak
Case 2
A 29 year old woman, gravida 3, para 3, was admitted to the hospital with irregular vaginal bleed-
ing since her last delivery 4 months previously. Since hCG serum levels remained elevated fol-
lowing the delivery she had been treated for one month with actinomycin with a presumed diag-
nosis of gestational trophoblastic disease. A tissue diagnosis could not be established at that time.
On admission ultrasound examination revealed an irregular lesion of about 2 cm in diameter in
the posterior wall of the uterus.
A total abdominal hysterectomy which included a vaginal segment was performed. The uter-
us measured 9×6×5 cm and weighed 120 gr. The external surface and the mucosal lining were
grossly unremarkable. The posterior wall of the uterus contained a 2 cm yellowish soft nodule
with a central necrotic, hemorrhagic focus. In the vaginal segment a nodule of about 1.5 cm was
noticed.
On microscopic examination the tumor nodule was composed of rounded and elongated cells
with distinct cell membranes. The nuclei were pleomorphic with clumped chromatin. Multinu-
cleated cells and giant nuclei were rare. The mitotic index was 9 mitoses per 10 hpf. Areas of
necrosis and fibrinoid material were observed.
The cells were positive for broad spectrum keratin and human placental lactogen as deter-
mined by the immunoperoxidase method on formalin fixed, paraffin embedded tissue. The en-
dometrium showed inactive glands.
Microscopic examination of the vaginal metastases revealed relatively few intermediate
trophoblastic cells. The majority of the tumor cells were of the syncytial-trophoblastic type with
some mitotic activity.
The lung specimen consisted of a fragment of 6×3×1,5 cm with intact pleura. On cut section
the lung parenchyma was replaced by a yellowish soft granular tumor. Histologically this me-
tastasis was composed of rounded and elongated atypical intermediate trophoblastic cells.
Immunohistochemical analyses of the primary tumor showed as in the first case a strong dif-
fuse positivity for cytokeratin (wide spectrum) and a weak positivity for CK 20 and EMA. Re-
activity for hCG was rare, whereas reactivity for hPL predominated (Fig. 4).
After treatment with methotrexate the serum hCG level became normal.
A vaginal recurrence measuring 1.8×1.5×0.5 cm occured 6 months later.
100 S. Remadi et al.
Fig. 4. Case 2: hPL reactive cells (A) are predominant when compared with hCG reactive cells
(B). (Immunoperoxidase ×300)
Twelve months after that the patient presented with pulmonary metastases. EMA-Co chemo-
therapy was administred and she achieved a short complete remission. Nevertheless the disease
progresses and debulking of a cystic lung tumor was carried out. The patient died 5 years after
the original diagnosis. No autopsy was performed.
Material and methods
Curettings from the case 1 and tissue from the uterine lesion in the case 2 were fixed in 10% neu-
tral buffered formalin, embedded in paraffin, and processed for light microscopy. Formalin-fixed,
paraffin-embedded sections were also evaluated immunohistochemically with the avidin-biotin
peroxidase complex technique using the following antibodies: cytokeratin (wide spectrum), cy-
tokeratin 20 (1/10, Progen), Vimentin (1/100, Dako), beta human chorionic gonadotropin (1/2000,
Dako), human placental lactogen (1/1000, Dako), epithelial membrane antigen (1/100, Dako).
The pulmonary metastatic nodule of case 1 was processed using the same technique as the
curettings material, and was evaluated immunohistochemically with the same antibodies. Mate-
rial for DNA image analysis was available only in the case 1. Tumor cells were stained accord-
ing the Feulgen method [19]. The instruments were calibrated with the use of lymphocytes on
the microscope slide. Tumor cells were individually selected for computerised DNA measure-
ment. Areas of necrosis were excluded. Feulgen concentration was converted by the computer
into a measurement of nuclear DNA content.
Discussion
The PSTT was originally termed “atypical chorioepithelioma” by Marchand in
1895 [16]. In 1976, under the title “trophoblastic pseudotumor of the uterus”, Kur-
man et al. [12] recognized the entity as a form of trophoblastic disease, distinct
from choriocarcinoma. Five years later, Scully and Young [21] introduced the term
“placental site trophoblastic tumor” to indicate possible malignant behaviour. Since
the first report, approximately 90 cases of PSTT have been reported, formerly
termed atypical choriocarcinoma [18], chorioepitheliosis [20] or syncytioma [3].
PSTT is a disorder of the reproductive period, occuring at an average age of 
28 years [1, 17], although several cases have been reported in patients over 50 years
of age and in a postmenopausal women [17]. Patients present either with amenor-
rhea, or with abnormal bleeding, frequently accompanied with progressive uterine
enlargment [1, 4], suggesting pregnancy.
When the uterine growth ceases, the diagnosis of missed abortion is usually
made [12]. PSTT has been diagnosed after term pregnancies, spontaneous abor-
tions, or a prior hydatidiform mole [4, 7, 8, 24].
As PSTT contains little or no syncytiotrophoblast, it is often associated with
low serum levels of hCG, typically less than 1000 iu/l. Thus when a sensitive im-
munologic assay is used, pregnancy tests are always positive, leading to an initial
diagnosis of pregnancy [15]. The pathogenesis of PSTT is unclear. The immuno-
histochemical expression of hPL and hCG in PSTT closely resembles that in the
normal intermediate trophoblast, suggesting that PSTT represents a neoplastic
transformation of extravillous intermediate trophoblast which is a highly special-
ized distinctive form of trophoblast [9, 13].
PSTT is a neoplasm of capricious and enigmatic behaviour. It can be self-lim-
iting, curable by curettage alone. But 10 to 15% of cases can follow an agressive
course, leading to metastasis and death [1, 4, 8, 23]. Including our cases, approx-
imately 21 cases of metastatic PSTT have been reported [17, 21]. Lung metasta-
ses have been described only in a few cases [1, 2, 5, 8, 10, 17].
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In contrast to metastatic choriocarcinoma metastases of PSTT are only occa-
sionally cured by multiagent chemotherapy [10]. Twenty years after the first de-
scription of PSTT by Kurman et al. [12], authors are still searching for reliable pre-
dictors of outcome in microscopic features, immunohistochemical staining, and
DNA analysis [5, 14, 22].
In our two cases, the mean mitotic rates were respectively 9 and 13 mitotic fig-
ures per 10 high-power fields (hpf). Usually the aggressiveness of PSTT correlates
with the mitotic count [4, 8]. In the benign tumors, the mean mitotic count has been
2/10 hpf, however malignant tumors usually have more than 5 mitotic figures per
10 hpf [6, 7]. In some fatal cases, the mitotic rate was 2/10 hpf [7], proving that a
low mitotic rate is not an absolute indicator of good prognosis.
As observed in our cases, necrosis is more extensive in the malignant tumors,
compared with benign ones limited to the uterus [2, 8, 24]. Pleomorphism and vas-
cular invasion are common features of PSTT, but have no prognostic significance.
Immunohistochemical staining aids the characterization of PSTT and assists in
differential diagnosis [14]. In view of their epithelial nature, tumor cells stain in-
tensely with keratin. Typically PSTT shows the reverse staining pattern of chorio-
carinoma with most tumor cells staining positively for hPL, whereas only few cells
stain positively with hCG [14].
hCG immunoreactivity tends to be mainly localized to multinucleate inter-
mediate trophoblastic cells, whereas it is occasionally present in mononucleate 
IT cells [24]. hCG and hPL production reflect the level of trophoblastic matura-
tion. hPL synthesis indicates a relatively high level of trophoblastic maturation.
The more trophoblast cells mature, the less they produce hCG [14].
The percentage of tumor cells stained with hPL was raised in case 2, and rela-
tively low in case 1, when compared with hCG positive cells. We thus agree that
the reversed staining pattern cannot always be used as an indicator of poor prog-
nosis [8, 14].
Case 1 had an aneuploid tumor with a tetraploid DNA peak and a prominent 
S-phase fraction. To our knowledge DNA analysis has been done in eight cases of
PSTT [4, 5, 11]. In seven of them, the DNA histogram showed a diploid G 1 peak
and an S-phase fraction, ranging from 6% to 24.9% [4, 5, 11]. Five of these seven
patients were alive after a follow-up ranging from 9 months to 11 years, whereas
one patient died of multiple lung metastases. The seventh patient had paraaortic
lymph nodes and lung metastases, but was alive 15 months after presentation [4,
5, 11]. These finding suggest that DNA ploidy does not give a reliable prognosis.
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